Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	165.96	137.30	51.62
Graham Fair Price	-50.94	3.81	7.76
PEG	402.59	0.48	0.10
Price/Book	-32.32	0.21	0.30
Price/Cash Flow	-98.10	-4.88	256.37
Prices/Earnings	-172.62	-35.73	-13.11
Price/Sales	92.66	0.84	0.44
Price/FCF	-98.10	-4.88	256.37
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-4.68	0.11	0.11
Operating Margin	86.29	0.01	< 0.005
ROA	74.49	< 0.005	< 0.005
ROE	< 0.005	< 0.005	75.17
ROIC	< 0.005	< 0.005	-39.74
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.01	98.44
Dividends QOQ	2.59	-0.73	-71.79
EBIT QOQ	-0.87	-0.35	60.15
EPS QOQ	-1.38	0.75	-45.76
FCF QOQ	1.08	-36.51	3274.70
Revenue QOQ	0.96	-0.65	-32.54
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	406.09	1101.16	171.16
Days Sales Outstanding (DSO)	170.71	511.80	199.80
Inventory Turnover	0.22	0.08	-63.12
Debt/Capitalization	0.58	0.58	0.02
Quick Ratio	0.53	0.54	2.60
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	21.45	21.12	-1.55
Cash	8.54	7.00	-18.02
Capex	-0.29	-0.10	65.80
Free Cash Flow	0.03	-0.89	3398.29
Revenue	15.01	5.19	-65.41
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.40	1.38	-1.07
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	39.28	114.53	191.54
Naive Interpretation	Member

06 - Financial Health · Weak

Rating